.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Daiichi Sankyo
Cipla
Colorcon
Dow
Covington
Teva
Chubb
Express Scripts
Moodys

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065017

« Back to Dashboard

NDA 065017 describes CYCLOSPORINE, which is a drug marketed by Apotex, Ivax Sub Teva Pharms, Mayne Pharma, Sandoz, Luitpold, West-ward Pharms Int, Abbvie, Apotex Inc, and Wockhardt, and is included in eleven NDAs. It is available from eleven suppliers. Additional details are available on the CYCLOSPORINE profile page.

The generic ingredient in CYCLOSPORINE is cyclosporine. There are seventeen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.

Summary for 065017

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Immunological Agents
Ophthalmic Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 065017

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYCLOSPORINE cyclosporine CAPSULE;ORAL 065017 ANDA Eon Labs, Inc. 0185-0932 0185-0932-30 30 BLISTER PACK in 1 CARTON (0185-0932-30) > 5 CAPSULE in 1 BLISTER PACK (0185-0932-86)
CYCLOSPORINE cyclosporine CAPSULE;ORAL 065017 ANDA Eon Labs, Inc. 0185-0933 0185-0933-30 30 BLISTER PACK in 1 CARTON (0185-0933-30) > 5 CAPSULE in 1 BLISTER PACK (0185-0933-86)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Jan 13, 2000TE:AB1RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength25MG
Approval Date:Jan 13, 2000TE:AB1RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
Fish and Richardson
Covington
Argus Health
Queensland Health
Moodys
Cantor Fitzgerald
Harvard Business School
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot